z-logo
Premium
HPV ‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis
Author(s) -
RodríguezCarunchio L,
Soveral I,
Steenbergen RDM,
Torné A,
Martinez S,
Fusté P,
Pahisa J,
Marimon L,
Ordi J,
Pino M
Publication year - 2015
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.13071
Subject(s) - medicine , cervix , oncology , negativity effect , gynecology , cervical cancer , cancer , carcinoma , gastroenterology , psychology , social psychology
Objective Using highly sensitive polymerase chain reaction ( PCR ) techniques, we reanalysed all cervical carcinomas ( CC s) found to be human papillomavirus ( HPV )‐negative by Hybrid Capture 2 ( HC 2) to determine the prevalence of true HPV ‐negativity. We also evaluated the characteristics of the patients with tumours with confirmed HPV ‐negativity. Design Observational study. Setting Barcelona, Spain. Population A cohort of 136 women with CC (32 adenocarcinomas, 104 squamous cell carcinomas) who had pre‐treatment HC 2 testing. Methods All negative cases were reanalysed and genotyped for HPV using three PCR assays ( SPF 10, GP 5+/6+ and E7‐specific assay). Main outcome measures Percentage of confirmed HPV ‐negative and HPV ‐positive tumours. Clinicopathological features and disease‐free survival ( DFS ) and overall survival ( OS ) of both groups. Results Fourteen of 136 women (10.2%) were negative for HPV by HC 2. After reanalysis by PCR ‐based techniques only 8/136 (5.8%) tumours were confirmed as HPV ‐negative, whereas in six cases different HPV s were identified [ HPV –11, −16 (two tumours), −18, −45, and −68]. Confirmed HPV ‐negativity was more frequent in adenocarcinomas than in squamous cell carcinomas (5/32, 15.6% versus 3/104, 2.9%, respectively; P  = 0.017). Patients with CC s with confirmed HPV ‐negativity had significantly worse DFS than women with HPV ‐positive tumours [51.9 months (95%  CI 12.2–91.7 months) versus 109.9 months (95%  CI 98.2–121.5 months); P  = 0.010]. In the multivariate analysis HPV ‐negativity and International Federation of Gynecology and Obstetrics ( FIGO ) staging were associated with increased risk of progression and mortality. Conclusions An HC 2‐negative result is an uncommon finding in women with CC , but in almost half of these cases HPV s are identified by more sensitive techniques. CC s with confirmed HPV ‐negativity are more frequently adenocarcinomas, and seem to be associated with worse DFS .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom